Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Akero Therapeutics Inc. logo

Akero Therapeutics Inc.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

21.78
 
USD
  
-0.38
  
(-1.71%)
Optionable: Yes  Market Cap: 1,532 M  90-day average vol: 740,060

Previous close: 22.16  Open: 21.89  Bid: 21.23  Ask: 22.05
52 week range    
11.25   
   53.77
Last updated: Friday 21st June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

AKRO Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-2.52-2.89-2.87-2.89
Basic EPS total-2.52-2.89-2.87-2.89
Basic weighted shares outstanding15 M31 M35 M39 M53 M
Diluted EPS total-2.9-2.52-2.89-2.87-2.89
Diluted normalized net income/share-2.9-2.89-2.87-2.89
Diluted weighted shares outstanding15 M31 M35 M39 M53 M
GainOnSaleOfSecurity-6000.0
GeneralAndAdministrativeExpense9 M15 M19 M30 M31 M
Income before tax-44 M-79 M-101 M-112 M-152 M
Income taxes-688000.0-21 M31 M42 M68 M
Interest income4 M24 M
InterestExpenseNonOperating739000.03 M
MiscOtherSpecialCharges2 M947000.0109000.0-264000.0-79000.0
Net income from total operations-44 M-79 M-101 M-112 M-152 M
NetIncomeCommonStockholders-44 M-79 M-101 M-112 M-152 M
NetIncomeContinuousOperations-44 M-79 M-101 M-112 M-152 M
NetNonOperatingInterestIncomeExpense3 M21 M
Normalized income-120 M
Operating income-46 M-80 M-101 M-115 M-173 M
Operating income before depreciation (EBITDA)-44 M-79 M-100 M-111 M-158 M
OperatingExpense46 M80 M101 M115 M173 M
Other income net-2 M-950000.0-85000.0-64000.0-233000.0
OtherGandA9 M15 M19 M30 M31 M
OtherOperatingExpenses-237000.0-407000.0-603000.0-746000.0-1 M
RentAndLandingFees-305000.0
Research & development expense37 M65 M82 M85 M142 M
ResearchExpense37 M65 M82 M85 M142 M
Revenue per share204000.0448000.0
SalariesAndWages-2 M
Selling Gen & administrative expense9 M15 M19 M30 M31 M
Total Income available for interest expense (EBIT)-44 M-79 M-101 M-111 M-148 M
Total common shares outstanding29 M35 M35 M47 M
Total net income-44 M-79 M-101 M-112 M-152 M
Total ordinary shares69 M69 M69 M69 M69 M
TotalExpenses46 M80 M101 M115 M173 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University